Core Insights - NetraMark Holdings Inc. has entered into a partnership with AlgoTherapeutix SAS to utilize its NetraAI platform for analyzing patient-level data from AlgoTx's ATX01 program, aimed at enhancing clinical trial design for chemotherapy-induced peripheral neuropathy (CIPN) [1][2][3] Company Overview - NetraMark is focused on developing Generative Artificial Intelligence (Gen AI) and Machine Learning (ML) solutions for the pharmaceutical industry, utilizing a novel topology-based algorithm to analyze patient data [6] - AlgoTherapeutix is a clinical-stage biotechnology company developing a first-in-class therapeutic for peripheral neuropathic pain, specifically targeting chemotherapy-induced peripheral neuropathy with its lead asset, ATX01 [8][9] Partnership Details - The collaboration will leverage NetraAI's technology to explore drug and placebo response variables, identify responder personas, and develop enrichment strategies for future ATX01 trials [2][4] - NetraMark will create customized AI models and interactive tools to assist AlgoTx in testing hypotheses and characterizing patient subpopulations, aiming to generate validated and regulator-ready insights [5][4] Product Information - ATX01 is a proprietary topical formulation of amitriptyline designed to provide targeted relief from pain associated with CIPN, which affects 68% of cancer treatment patients [9][10] - The product has received FDA fast track development status, indicating its potential significance in addressing a high unmet medical need [9] Financial Background - AlgoTx raised EUR 20 million in a Series B funding round in 2023, bringing its total funding to EUR 35 million, supported by a consortium of investors [11]

Technology & Development - Open-source tools enable building production-grade LLM web apps rapidly [1] - Interactive apps are more suitable for users focused on results rather than code [1] Data Science & Machine Learning - Data scientists and machine learning engineers commonly use Jupyter for data exploration and model building [1] - Tutorials and insights on DS, ML, LLMs, and RAGs are shared regularly [1]

AI Development & Capabilities - AI capabilities are continuously improving, surpassing previous expectations in areas like math and coding, outperforming most humans on most tasks [1] - Initial concerns about limitations due to training data scarcity have been overcome by new paradigms like Reinforcement Learning (RL) [2] - AI exhibits forms of reasoning through methods like chain-of-thought (CoT), scratch pads, and Python tools, enabling them to reach impressive conclusions [2] Perspective on AI Progress - The author views the current world as witnessing the emergence of a potentially superior intelligence that is steadily improving [2] - The author expresses frustration with the inability of others to embrace the realistic prospects that current models are likely to be broken soon [6] - The author likens the current human understanding of AI to a chimpanzee studying the arrival of humans, implying a limited comprehension of AI's potential [2][3] Implications of AI - The evolution of superior intelligence, whether biological or artificial, requires iterations and feedback from the universe [4] - The substrate of intelligence has shifted to silicon, allowing for faster iterations and greater malleability [4][5]

Sharing recent progress from Physical Intelligence and why it is an exciting time to push the frontier in general purpose robotics About Quan Vuong Quan Vuong is co-founder at Physical Intelligence. His research focuses on generalist robotics and algorithms that enable intelligent behaviors through large scale learning. About Jost Tobias Springenberg Tobias is currently a research scientist at Physical Intelligence where he works on bringing AI into the real world and understanding the fundamentals of seque ...

Core Insights - The S&P 500 is a leading U.S. stock market index comprising 500 companies from 11 sectors, selected based on strict criteria to ensure high quality [1] - The S&P 500 has delivered a compound annual return of 10.5% since its inception in 1957, making it a recommended investment by experts like Warren Buffett [2] Investment Options - Younger investors or those with a higher risk appetite may consider alternative investments with greater growth potential [3] - The Vanguard Growth ETF aims to track the CRSP US Large Cap Growth Index, which includes companies representing 85% of the market capitalization of the CRSP US Total Market Index [5][6] - The Vanguard Growth ETF holds 165 stocks, with its top five holdings (Microsoft, Nvidia, Apple, Amazon, Meta Platforms) accounting for 44.2% of its portfolio [8] - Over the last decade, the Vanguard Growth ETF generated a compound annual return of 16.2%, outperforming the S&P 500's 12.8% [10] - Since its establishment in 2004, the Vanguard Growth ETF has achieved a compound annual return of 11.8%, compared to the S&P 500's 10.1% [11] Vanguard Mega Cap Growth ETF - The Vanguard Mega Cap Growth ETF tracks the CRSP US Mega Cap Growth Index, focusing on companies that make up 70% of the market cap of the CRSP US Total Market Index [13][14] - This ETF holds 69 stocks, with its top five holdings representing 50.3% of its portfolio [14] - The Vanguard Mega Cap Growth ETF has delivered a compound annual return of 13.4% since its inception in 2007, surpassing the S&P 500's 10.2% [15] Sector Concentration - The technology sector constitutes 60.4% of the Vanguard Growth ETF and 63.9% of the Vanguard Mega Cap Growth ETF [17] - High concentration in technology stocks has led to significant returns but also exposes investors to risks if these stocks experience corrections [17][18]

General Overview - The document is a wrap-up and encourages sharing with the network [1] - It directs readers to Avi Chawla's profile for tutorials and insights on DS, ML, LLMs, and RAGs (Data Science, Machine Learning, Large Language Models, and Retrieval-Augmented Generation) [1] Focus Area - Avi Chawla's content includes explanations of Agentic AI systems [1]

Company Overview - GeneDx Holdings is a healthcare technology company that integrates AI and machine learning with clinical and genomic data, focusing on precision medicine and individualized patient care [7] - The company has a market capitalization of $2.29 billion and reported a revenue of $330 million with a net income of -$38.6 million for the trailing twelve months [6] Recent Financial Performance - GeneDx Holdings shares have appreciated by 141.5% over the past year as of July 11, 2025 [5] - The company reported a 42% year-over-year increase in revenue for the first quarter, driven by high volumes of exome and genome tests [9] - Revenue from exome and genome tests accounted for 82% of GeneDx's total Q1 revenue, with the net loss for the quarter shrinking to $6.5 million from $20 million in the prior-year period [10] Insider Activity - On July 11, 2025, Kevin Feeley, CFO of GeneDx Holdings, sold 5,278 shares, reducing his holdings to 3,392 shares, which represents approximately 0.01% of total shares outstanding [1][4] - This sale is consistent with Feeley's recent trading patterns, as it is near the median trade size for him over the last several quarters [3] Growth Catalysts - GeneDx has strong growth prospects, particularly following its acquisition of Fabric Genomics, which enhances its AI-driven test interpretations and expands its genomics testing portfolio [12] - The company is targeting a larger patient population by expanding testing to outpatient pediatrics, NICU patients, and newborns [11] - Management has raised its full-year revenue guidance to a range of $360 million to $375 million, up from the previous forecast of $350 million to $360 million [10]

Core Insights - Seagate Technology Holdings plc is set to report its fourth-quarter fiscal 2025 earnings on July 29, with earnings estimated at $2.46 per share, reflecting a year-over-year increase of 134.3% and revenues projected at $2.41 billion, indicating a 27.5% rise from the previous year [1] Group 1: Earnings and Revenue Expectations - The management anticipates quarterly revenues of $2.4 billion, with non-GAAP earnings expected to be $2.4 per share [1] - Seagate has consistently beaten the Zacks Consensus Estimate in the past four quarters, with an average surprise of 15.67% [1] - The expected mass capacity revenues for Q4 are projected to rise 39.5% year over year to $2 billion [7][8] Group 2: Market Demand and Product Strategy - There is a rising demand for mass capacity storage driven by increasing nearline cloud requirements, aligning with cloud investment cycles and AI-ready data center expansions [2] - Seagate's high-capacity nearline products are experiencing strong demand from cloud customers globally, contributing to increased revenues and profits [3] - The launch of the Mozaic 3+ hard drive platform featuring HAMR technology is expected to enhance Seagate's market share in mass capacity storage solutions [4] Group 3: Technology and Production - Seagate's technology strategy is focused on ramping up HAMR technology to meet the growing demand from cloud customers, with Mozaic drives being the only products in the industry offering 3 terabytes per disk [5] - The company has significantly increased production of its 24-28 terabyte PMR drives, which are now its top-selling product line in terms of revenue and exabyte shipments [4] Group 4: Financial Performance and Margins - The gross margin for the fiscal fourth quarter is projected at 36.8%, an increase from 30.9% in the prior year, driven by strong nearline demand and optimized pricing [9] - Revenue estimates for the HDD segment are pegged at $2.25 million, reflecting a 30.1% increase from the previous year, while the non-HDD segment is expected to decline by 3.4% [8]

AI Learning Resources - Offers a free illustrated guidebook on MCP (Model Compression and Pruning) fundamentals [1] - The guidebook contains 75+ pages [1] - Includes 11 hands-on projects for AI engineers with code examples [1] Content Focus - Focuses on DS (Data Science), ML (Machine Learning), LLMs (Large Language Models), and RAGs (Retrieval-Augmented Generation) [1] - Provides tutorials and insights on these topics [1]

AI Team Anatomy - Companies should recognize that technology is not always the limitation to success, but rather how technology is used [1] - Companies need to identify their bottlenecks, such as shipping features, acquiring/retaining users, monetization, scalability, and reliability, to prioritize hiring accordingly [3][4] - Companies should consider whether to trade their existing team with domain knowledge for AI researchers from top labs, weighing the value of domain expertise against specialized AI skills [1] Generalists vs Specialists - Companies should structure AI teams comprehensively, recognizing that success isn't tied to a single role [2] - Companies should prioritize building a comprehensive AI team with skills in model training, model serving, and business acumen, balancing budget constraints [7] - Companies should understand the trade-offs between hiring generalists and specialists, with generalists being adaptable and specialists pushing for extra performance [18][19] Upskilling and Hiring - Companies should focus on upskilling employees in building, domain expertise, and human interaction [19] - Companies should hire based on the need to hold context and act on context, ensuring accountability for AI systems [23][24][25] - Companies should verify trends and think from first principles when hiring, considering new grads, experienced professionals, and retraining opportunities [27]